Caitlin Cornwall

Caitlin Cornwall has a strong background in clinical operations and project management within the biopharmaceutical industry. Caitlin currently serves as an Associate Director of Clinical Operations at Goldfinch Bio, where they have been since August 2021. Prior to this, Caitlin worked as a Senior Clinical Trial Manager at Goldfinch Bio from February 2020 to July 2021.

Before joining Goldfinch Bio, Caitlin was a Senior Clinical Trial Manager at Moderna from July 2019 to January 2020, focusing on rare diseases. Prior to that, they held various roles at Corbus Pharmaceuticals from 2016 to 2019. Notably, they served as a Clinical Project Manager from January to June 2019, overseeing the successful launch of a global Phase III Dermatomyositis study. Caitlin also held the position of Clinical Research Associate Manager, where they were responsible for line management and the professional development of 13 direct reports.

Caitlin began their career as a Clinical Research Associate at Parexel from June 2014 to March 2016. Overall, Caitlin brings extensive experience in clinical operations, project management, and line management to their current role at Goldfinch Bio.

Caitlin Cornwall has a Master of Science (MS) degree in Business Innovation from the D'Amore-McKim School of Business at Northeastern University. Caitlin also has a Graduate Certificate in Biopharmaceutical International Regulatory Affairs from Northeastern University. Prior to their graduate studies, Caitlin earned a Bachelor of Arts (BA) degree in Biology from Wesleyan University. Caitlin also spent some time as an Affiliate Student at UCL, studying Biological Sciences. Finally, they obtained their High School Diploma from the Maine School of Science and Mathematics (MSSM).